Regenxbio is exploring a new hereditary angioedema (HAE) treatment that harnesses viral vectors…
Articles by Alice Melao
Attune Pharmaceuticals’ ATN-249, an investigational kallikrein inhibitor for the prevention of swelling attacks in hereditary angioedema (HAE) patients, was…
KalVista Pharmaceuticals’ investigational candidate KVD900, being developed for the treatment of hereditary angioedema (HAE), is safe and…
Angioedema seems to predict poorer responses and lower chances of remission in chronic urticaria patients receiving Xolair (omalizumab), a retrospective…
The U.S. Food and Drug Administration has rejected Pharming’s request to expand the label of Ruconest (conestat…
Medications that lower cholesterol levels, collectively known as statins, can in rare instances trigger angioedema episodes that are self-resolving if…
The U.S. Food and Drug Administration (FDA) has granted fast track status to BCX7353, an investigational therapy being developed by…
Activase (alteplase), a common treatment for stroke, may trigger angioedema of the mouth and tongue that can lead to…
Entresto (sacubitril/valsartan) — an approved medication for heart failure — does not significantly increase the risk of angioedema compared…
Treatment with human plasma-derived C1-INH is an effective and safe option for managing symptoms of severe hereditary angioedema during pregnancy…